Remdesivir Needs More Trials Before Going All In: MMKCC's Bach

Remdesivir Needs More Trials Before Going All In: MMKCC's Bach

Dr. Peter Bach, Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes, on his column: "Hospitals Need to Study How Well Remdesivir Works." Alan Crawford, Senior International Government Editor for Bloomberg, discusses his story, "A New World Order for the Coronavirus Era Is Starting to Emerge." Woo Jin Ho, Senior Technology Analyst for Bloomberg Intelligence, discusses Analog Devices buying Maxim for $21 billion, and how this impacts the landscape for chips. Matt Gertken, Geopolitical Strategist at BCA Research, on why Trump needs to side with the Dems and go big on the next round of stimulus. Hosted by Paul Sweeney and Vonnie Quinn.

See omnystudio.com/listener for privacy information.

Episoder(3343)

Coronavirus Is Dominating The U.S. Due To Failure To Control It

Coronavirus Is Dominating The U.S. Due To Failure To Control It

Dr. Amesh Adalja, Senior Scholar and Infectious Disease physician at the Johns Hopkins Center for Health Security, on Trump's return to the White House, and the super-spreader event at the Rose Garden...

6 Okt 202029min

Political 'Mess' Is Clouding Strategy: Federated's Orlando

Political 'Mess' Is Clouding Strategy: Federated's Orlando

Phil Orlando, Chief Equity Market Strategist and Head of Client Portfolio Management at Federated Hermes, on how the election and White House covid crisis are clouding investment strategy. Bess Freedm...

5 Okt 202028min

How Chaos In DC Is Impacting The Economy: FHN's Low

How Chaos In DC Is Impacting The Economy: FHN's Low

Chris Low, Chief Economist at FHN Financial, on how markets view Trump's covid diagnosis and the election, and his current economic outlook. Tom Gimbel, CEO of global staffing company LaSalle Network,...

2 Okt 202029min

A 2-6-Month Lasting 'Vaccine' Could Soon See Approval: Fazeli

A 2-6-Month Lasting 'Vaccine' Could Soon See Approval: Fazeli

Sam Fazeli, Senior Pharmaceutical Analyst and Head of EMEA Research at Bloomberg Intelligence, on his column: "Trump Could Get His Vaccine Before Election Day." Jessica Caldwell, Executive Director of...

1 Okt 202028min

Disney Cuts Lay Bare That 'Normal' Isn't On The Horizon

Disney Cuts Lay Bare That 'Normal' Isn't On The Horizon

Tara Lachapelle, Bloomberg Opinion media columnist, discusses her column: "Not Even Disney Can Live on Dreams Forever." Bryan Whalen, Group Managing Director for TCW’s Fixed Income Group, on sticking ...

30 Sep 202029min

Ex-CDC Director: Slim Chance To Contain NYC Covid Clusters

Ex-CDC Director: Slim Chance To Contain NYC Covid Clusters

Dr.Tom Frieden, former CDC Director and President and CEO of Resolve to Save Lives, on the surge in coronavirus cases. Brooke Sutherland, Bloomberg Opinion deals and industrials columnist, discusses h...

29 Sep 202030min

Financially-Squeezed Trump Is A National Security Risk: O'Brien

Financially-Squeezed Trump Is A National Security Risk: O'Brien

Timothy O'Brien, Senior Columnist for Bloomberg Opinion, discusses his column: "Trump's Taxes Show He's a National Security Threat." "Banker to the World" Bill Rhodes, former Chairman of Citibank and ...

28 Sep 202029min

Amy Coney Barrett's Impact on the Supreme Court

Amy Coney Barrett's Impact on the Supreme Court

President Donald Trump says he will nominate Judge Amy Coney Barrett for the Supreme Court. If confirmed by the Senate, Barrett could cement the court’s rightward shift for a generation.Bloomberg's Da...

27 Sep 202029min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
rss-borsmorgen-okonominyhetene
utbytte
pengepodden-2
pengesnakk
livet-pa-veien-med-jan-erik-larssen
rss-sunn-okonomi
morgenkaffen-med-finansavisen
tid-er-penger-en-podcast-med-peter-warren
okonomiamatorene
finansredaksjonen
lederpodden
liberal-halvtime
rss-markedspuls-2
rss-impressions-2
rss-andelige-tanker-med-camillo